Takeda Pharmaceutical Company Limited Current Provisions
Takeda Pharmaceutical Company Limited (TAK) had Current Provisions of JPY 533.14 billion as of 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Notes
ifrs-full:CurrentProvisions · last filed 2025-06-25
- 2025-03-31: Current Provisions 533.14B JPY.
- 2024-03-31: Current Provisions 524.42B JPY.
- 2023-03-31: Current Provisions 508.36B JPY.
- 2022-03-31: Current Provisions 443.50B JPY.
| Period end | Current Provisions | Current Provisions as first filed |
|---|---|---|
| 2025-03-31 | 533.14B JPY 20-F · filed 2025-06-25 | |
| 2024-03-31 | 524.42B JPY 20-F · filed 2025-06-25 | |
| 2023-03-31 | 508.36B JPY 20-F · filed 2025-06-25 | |
| 2022-03-31 | 443.50B JPY 20-F · filed 2024-06-26 | |
| 2021-03-31 | 471.28B JPY 20-F · filed 2023-06-28 | |
| 2020-03-31 | 405.25B JPY 20-F · filed 2022-06-29 | |
| 2019-03-31 | 387.13B JPY 20-F · filed 2021-06-29 | 392.73B JPY 20-F · filed 2019-06-27 |
| 2018-03-31 | 132.78B JPY 20-F · filed 2020-06-24 | |
| 2017-03-31 | 135.80B JPY 20-F · filed 2019-06-27 |